New Hampshire Lawmakers Approve Marijuana Legalization. Jeff Sessions would surely be pissed.

rsz-NH-lawmakers-approve-decriminalization-of-cannabis-640x401.jpg

The New Hampshire House of Representatives voted to legalize marijuana on Tuesday, just five days after the Trump administration moved to rescind federal guidelines protecting state cannabis laws.

Under the bill, which is expected to soon move to the state Senate, people over 21 years of age would be allowed to legally possess three-quarters of an ounce of marijuana and grow up to three mature cannabis plants at home. Retail sales locations would not be allowed.

The noncommercial approach is similar to a bill advancing in neighboring Vermont. There, the House passed a legalization measure on Thursday -- the same day U.S. Attorney General Jeff Sessions tore up Obama-era marijuana guidance. That state's Senate, which previously OKed similar legislation, is expected to give its final approval on Wednesday, and Gov. Phil Scott (R) has pledged to sign legalization into law.

The swift action by the two states represents a stunning rebuke to the Trump administration's anti-cannabis move, which was also roundly slammed by dozens of members of Congress from both parties.

In New Hampshire, the House voted to amend a broader bill that would have allowed legal, taxed and regulated marijuana sales. The legislation, as introduced, was defeated in committee in November. Opponents argued that because a legislative study commission is currently examining how legalized marijuana commerce might work in the state, passing the bill now would be premature.

On Tuesday, supporters successfully moved a floor amendment to scale the proposal back to only legalize possession and home cultivation.

Hear Andy's story. A journey from an ADHD patient to a successful Gardner. thanks to cannabis.

Andy1.jpg

When Andy McConville suffered a mental health crisis he realised he could put his green fingers to better use.

Andy McConville has landed his dream job - and he owes it all to the fact he used to be a cannabis farmer.

The 34-year-old horticultural specialist spent a decade growing weed for his own use at home.

It was only when he suffered a mental health crisis about three years ago that he realised he could put his green fingers to better use.

He initially began smoking cannabis to help him cope with the symptoms of what he now knows is ADHD.

But after a while his drug use began to take its toll.

Andy estimates that he’s had between 250 to 280 jobs since he left school at the age of 15. He got his first job working for a plasterboard company, and has had scores of trade jobs ever since, from being a plumber, to joiner, fork lift driver to warehouse assistant. He’s also worked at an ice cream factory, which he said was great for getting free choc ices for lunch, and has been employed as a dog walker.

Following his diagnosis Andy, who grew up in Tameside, decided to put his gardening skills to good use.

“He asked me what I enjoyed doing most and I said ‘growing’. It was a weird thing, I stumbled on it myself, but I knew straight away that’s where I found peace.”

He enrolled on a horticultural course at Hopwood Hall College in Rochdale, and began volunteering at a community allotment run by homeless charity Petrus in the town.

And he now works at Todmorden Incredible Aqua Garden - a state-of-the-art hydroponics, aquaponics and permaculture garden centre.

Watch his full interview on the link given below to know it word by word for a better future. 

 

GD Pharma becomes first company in South Australia to begin cannabis extractions

0fb815c7c720617c377c328d8eeccf34.jpeg

An Adelaide company is to become the first in South Australia to begin cannabis extractions and create market-ready products from a secret laboratory in the city.

GD Pharma has been importing cannabis components from overseas but under its new manufacturing licence it will be able to import the plants, extract the chemicals, and produce a range of experimental prescription products.

Chief executive Antony Condina said it meant they could control the concentration of cannabis to create tailor-made products for a wide range of clients.

Some 266 patients are approved to use medicinal cannabis Australia-wide.

He said the main hurdle to achieve the manufacturing license was the risk of cannabis being shifted into the black market, including risks of theft and being "held up".

GD Pharma's secret new factory will operate by the end of year and would take about one week to produce a batch of diluted resin that costs about $500 for a bottle.

Mr Condina said they were unlikely to draw a profit because red tape restricted doctors' ability to prescribe cannabis.

"Last year it was estimated about 100,000 Australians would benefit from medicinal cannabis but, in reality, there's only been around 100 patients in 11 months who have been approved for products."

Proponents say there is evidence to suggest cannabis products can help with conditions like multiple sclerosis, severe intractable epilepsy in children, intractable nausea and vomiting due to chemotherapy.

Those opposing it, however, along with the Federal Department of Health, have cited a lack of quality research along with ongoing investigations and trials as the reason for restrictions.

Meet Hillary Peckham: The 25 years old young entrepreneur and one of the five licensed cannabis producers for New York

hillary.JPG

Hillary Peckham is just 25 years old, but she is already the Chief Operations Officer for Etain, LLC, the only woman-owned, family-run medical marijuana registered organization in New York.

Etain was awarded one of just five coveted licenses to produce medical cannabis in New York. The license includes a 22,000-square-foot cultivation and processing facility and four dispensary locations across the state, in Kingston, Albany, Syracuse, and Yonkers.

Since opening doors in January 2016, Etain watched the medical cannabis program in New York grow from just 51 patients to more than 31,000. With the addition of chronic pain as a qualifying condition, the program will only continue to expand and has inspired at least one new product from the dispensary.

Read the full interview conducted by Leafy by clicking on the link given below.

hillary-peckham-2-300x300.jpg